BNP Paribas Financial Markets Takes $1.31 Million Position in Option Care Health, Inc. (NASDAQ:OPCH)

BNP Paribas Financial Markets acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 56,488 shares of the company's stock, valued at approximately $1,311,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of OPCH. Cornerstone Investment Partners LLC grew its position in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock worth $221,000 after acquiring an additional 333 shares in the last quarter. UMB Bank n.a. grew its position in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares in the last quarter. Assetmark Inc. grew its position in Option Care Health by 2.0% in the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company's stock worth $579,000 after acquiring an additional 487 shares in the last quarter. Pacer Advisors Inc. grew its position in Option Care Health by 2.2% in the fourth quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after acquiring an additional 537 shares in the last quarter. Finally, Sheets Smith Wealth Management lifted its stake in Option Care Health by 2.4% in the fourth quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company's stock worth $553,000 after purchasing an additional 550 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $33.09 on Tuesday. The business's fifty day moving average price is $33.07 and its 200 day moving average price is $29.12. The firm has a market capitalization of $5.42 billion, a PE ratio of 27.81, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.26 earnings per share. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.64% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on OPCH. Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities restated a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.